Abbott | الربح الإجمالي على المبيعات



Gross Profit On Sales تغيير تاريخ
Abbott USD 5.92B 114M 2025-03
Agilent USD 899M 18M 2025-01
AtriCure USD 92.63M 9K 2025-03
Baxter International USD 1.02B 19M 2024-12
Becton, Dickinson and Co. USD 2.26B 22M 2025-03
Bio-Rad Laboratories USD 310.6M 44.5M 2025-03
Boston Scientific USD 3.2B 97M 2025-03
Cooper Companies USD 660.2M 17.5M 2025-01
Danaher USD 3.53B 364M 2025-03
Dexcom USD 589M 120.3M 2025-03
Edwards Lifesciences USD 1.11B 17.5M 2025-03
Globus Medical USD 402.72M 8.87M 2025-03
Hologic USD 560.7M 19.8M 2025-03
Insulet USD 409M 21.9M 2025-03
Integra LifeSciences USD 215.14M 50.7M 2025-03
Intuitive Surgical USD 1.46B 184.5M 2025-03
J&J USD 14.6B 816M 2025-03
Masimo USD 234M 10.7M 2025-03
Medtronic USD 5.52B 49M 2025-01
Merit Medical Systems USD 172.02M 963K 2025-03
Pfizer USD 11.12B 987M 2025-03
Smith & Nephew USD 2.07B 98M 2024-12
Solventum Corp 1.12B 5M 2025-03
Stryker USD 3.81B 385M 2025-03
Tandem Diabetes Care USD 118.41M 39.05M 2025-03
Teleflex USD 389.44M 50.48M 2025-03
Terumo JPY 138.53B 6.59B 2025-03
Thermo Fisher Scientific USD 4.31B 514M 2025-03
Zimmer Biomet Holdings USD 1.44B 150.9M 2024-12



Abbott الربح الإجمالي على المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.